Rosenblatt cuts Varonis stock rating on Thoma Bravo acquisition
Rosenblatt downgraded Varonis Systems (VRNS) to Neutral with a $49.75 price target after its $6.3B acquisition by Thoma Bravo-owned Proofpoint. The deal offers a 52% premium over pre-rumor prices and a 17% premium over recent prices. VRNS trades at $47.34, with high gross margins but recent losses. Multiple analysts adjusted ratings to reflect the acquisition.
How this was made
The 30-second read
Why it matters
The acquisition is expected to close, removing execution risk and providing a clear exit for shareholders at a premium.
Market read
The deal provides a clear catalyst for VRNS, likely moving the stock toward the cash offer and influencing peer valuations in the cybersecurity sector.
What to watch
Potential antitrust review and the transition of Varonis' self‑hosted business to end‑of‑life in 2026 could affect long‑term value.
Background
Rosenblatt and several other analysts downgraded Varonis following the announcement of the all‑cash acquisition by Proofpoint, aligning price targets with the $49.75 offer.
Ticker impact
Rosenblatt downgraded Varonis (VRNS) to Neutral and set a $49.75 price target after the company agreed to be acquired by Thoma Bravo-owned Proofpoint for $49.75 per share.
upward pressure as investors price in the 52% premium and cash deal.
Deal size (~$6.3 B) and premium are material; the stock is already trading just below the offer, so the news is likely to lift the price toward $49.75.
Market effects
The deal highlights continued consolidation in the cybersecurity/data‑protection sector, potentially prompting valuation reassessments for peers.
US cybersecurity stocks may see modest upside as the acquisition underscores strong M&A activity.
Limited to the cybersecurity niche; no broad market impact.
Counterpoint
If the acquisition faces regulatory delays or integration risks, the stock could slip below the offer price.
Key entities
- companyVaronis Systems
Cybersecurity data‑protection firm being acquired.
- companyProofpoint
Thoma Bravo‑owned acquirer.
- analyst_firmRosenblatt
Downgraded Varonis and set a new price target.

